Here's a Way to Bet on High-Conviction Value Picks
Justin Kuepper
|
While there are many value-focused ETFs, active funds have the flexibility to pinpoint...
In the previous deal, Valeant offered to acquire the company for $158 per share, or $14.5 billion. The offer was increased after Endo International (ENDP) expressed interest in acquiring Salix for $175 per share, or $11 billion.
The adjusted deal has been approved by the Boards of Directors of both companies.
Last year, Valeant’s deal to acquire Allergan (AGN) fell through, and since then, VRX has been seeking alternative deals.
Symbol | Mutual Fund | Stake |
---|---|---|
SEQUX | Sequoia | 3.36% |
PRGFX | T. Rowe Price Growth Stock | 1.33% |
SEEGX | JPMorgan Large Cap Growth Select | 0.68% |
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Receive email updates about best performers, news, CE accredited webcasts and more.
Justin Kuepper
|
While there are many value-focused ETFs, active funds have the flexibility to pinpoint...
Aaron Levitt
|
All in all, bonds may not be serving all investors' needs in this...
Aaron Levitt
|
Despite all the backlash and recent laws in several states condemning ESG, the...
Mutual Fund Education
Justin Kuepper
|
Let's take a closer look at how ESG investments have outperformed during the...
Mutual Fund Education
Daniel Cross
|
While CITs and mutual funds share many similarities, there are some key differences...
Mutual Fund Education
Sam Bourgi
|
The phrase ‘bear market’ has been thrown around a lot lately, but it...
In the previous deal, Valeant offered to acquire the company for $158 per share, or $14.5 billion. The offer was increased after Endo International (ENDP) expressed interest in acquiring Salix for $175 per share, or $11 billion.
The adjusted deal has been approved by the Boards of Directors of both companies.
Last year, Valeant’s deal to acquire Allergan (AGN) fell through, and since then, VRX has been seeking alternative deals.
Symbol | Mutual Fund | Stake |
---|---|---|
SEQUX | Sequoia | 3.36% |
PRGFX | T. Rowe Price Growth Stock | 1.33% |
SEEGX | JPMorgan Large Cap Growth Select | 0.68% |
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Receive email updates about best performers, news, CE accredited webcasts and more.
Justin Kuepper
|
While there are many value-focused ETFs, active funds have the flexibility to pinpoint...
Aaron Levitt
|
All in all, bonds may not be serving all investors' needs in this...
Aaron Levitt
|
Despite all the backlash and recent laws in several states condemning ESG, the...
Mutual Fund Education
Justin Kuepper
|
Let's take a closer look at how ESG investments have outperformed during the...
Mutual Fund Education
Daniel Cross
|
While CITs and mutual funds share many similarities, there are some key differences...
Mutual Fund Education
Sam Bourgi
|
The phrase ‘bear market’ has been thrown around a lot lately, but it...